Sequence specific modulation of DNA restriction enzyme cleavage by minor groove binders

Biological Chemistry

Volumn 379, Issue 4-5, 1998, Pages 519-525

  Kittler, Leonhard ^a   Bell, Achim ^a   Baguley, Bruce C ^b   Löber, Günter ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Enzyme inhibition; Footprints; Gel shift; Ligand binding

Indexed keywords

AMMONIUM DERIVATIVE; CIRCULAR DNA; DNA; DOUBLE STRANDED DNA; RESTRICTION ENDONUCLEASE;

CONFERENCE PAPER; CONTROLLED STUDY; DNA CLEAVAGE; DNA SEQUENCE; ELECTROPHORESIS; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

EID: 0031979649     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1998.379.4-5.519     Document Type: Conference Paper

References (43)

1. Baguley, B.C. (1982). Nonintercalative DNA-binding antitumour compounds. Molec. Cell. Biochem. 43, 167-181.
2. Bailly, C., and Waring, M.J. (1995). Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA. J. Biomolec. Struct. Dyn. 12, 869-898.
3. Bailly, C., and Henichart, J.P. (1991). DNA recognition by intercalator-minor-groove binder hybrid molecules. Bioconj. Chem. 2, 379-393.
4. Bell, A., Kittler, L., Löber, G., and Zimmer, Ch. (1996). Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides. Invest. Drug Design 13, 271-284.
5. Bell, A., Kittler, L., Löber, G., and Zimmer, Ch. (1997). DNA binding properties of minor groove binders relates to their influence on the topoisomerase II cleavage reaction. J. Molec. Recog., in press.
6. Birnboim, H.C., and Doly, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nuc. Acids Res. 7, 1513-1522.
7. Brabec, V., and Balcarova, U. (1993). Restriction-enzyme cleavage of DNA modified by platinum (II) complexes. Eur. J. Biochem. 216, 183-187.
8. Burckhardt, G., Zimmer, Ch., and Baguley, B. (1987). Binding of nonintercalative antitumor drugs to DNA-polymers: Structural effects of bisquaternary ammonium heterocycles. J. Biomolec. Struct. Dyn. 5, 813-831.
9. Chan, P.P., and Glaser, P.M. (1997). Triplex DNA, fundamentals, advances, and potential applications for gene therapy. J. Mol. Med. 75, 267-282.
10. Chen, S.M., Leupin, W., Rance, M., and Chazin, W.J. (1992). Two-dimensional NMR studies of d(GGTTAATGCGGT) · d(ACCG-CATTAACC) complexed with the minor groove binding drug SN 6999. Biochemistry 31, 4406-4413.
11. Cheng, X., Belendrian, K., Schildkraut, J., and Anderson, J.E. (1994). Structure of PvuII endonuclease with cognate DNA. EMBO J. 13, 3927-3935.
12. Cohen, J.S. (1991). Oligonucleotides as therapeutic agents. Pharmacol. Therap. 52, 211-225.
13. Denny, W.A., Atwell, G.J., Baguley, B.C., and Cain, B.F. (1979). Potential antitumor agents. Part. 29. Quantitative structure -activity relationship for the antileukemic bisquaternary ammonium heterocycles. J. Med. Chem. 22, 134-150.
14. Dabroviak, J.C., Goodisman, J., and Kissinger, K. (1992). Thermodynamic data from drug-DNA footprinting experiments. Biochemistry 29, 6139-6152.
15. 2 complex and comparison with the x-ray crystal structure. Structure 1, 177-186.
16. Forrow, S.M., Lee, M., Souhami, R.L., and Hartley, J.A. (1995). The effect of AT and GC sequence specific minor groove-binding agents on restriction endonuclease activity. Chem. Biol. Interact. 96, 125-142.
17. Francois, J.-Ch., Saison-Behmoaras, R., Thuong, N.T., and Hélène, C. (1989). Inhibition of restriction endonuclease cleavage via triple helix formation by homopyrimidine oligonucleotides. Biochemistry 28, 9617-9619.
18. Heitman, J. (1992). How the EcoRI endonuclease recognises and cleaves DNA. Bio essays 14, 445-454.
19. Herzyk, P., Neidle, S., and Goodfellow, J.M. (1992). Conformation and dynamics of drug-DNA intercalation. J. Biomolec. Struct. Dyn. 10, 97-139.
20. Hurley, L.H., and Boyd, F.L. (1987). Approaches toward the design of sequence-specific drugs for DNA. In: Annual Reports in Medical Chemistry. Vol. 22, R.C. Allen, ed. (London: Academic Press), pp. 259-273.
21. Jeltsch, A., Wenz, Ch., Wende, W., Selent, U., and Pingoud, A. (1996). Engineering novel restriction endonucleases: principles and applications. TIBTECH 14, 235-238.
22. Kim, J.L., Nikolov, D.B., and Burley, S.K. (1993). Co-crystal structure of TBP recognising the minor groove of a TATA element. Nature 365, 520-527.
23. Kittler, L., and Löber, G. (1995). Sequence specificity of DNA-psoralen photoproduct formation in supercoiled plasmid DNA (pUC19). Photochem. Photobiol. 27, 161-166.
24. Kittler, L., Wähnert, U., Baguley, B.C., Bailly, C., Waring, M.J., and Löber, G. (1996a). Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitro. Anti-Cancer Drug Design 11, 101-115.
25. Kittler, L., Bell, A., Baguley, B.C., and Löber, G. (1996b). Inhibition of restriction endonucleases by DNA sequence-reading ligands. Biochem. Molec. Biol. Inter. 40, 263-272.
26. Lavery, R., and Pullman, B. (1985). The dependence of the surface electrostatic potential of B-DNA on environmental factors. J. Biomolec. Struct. Dyn. 2, 1021-1035.
27. Lavery, R., Zakrzewska, K., and Pullman (1986). Binding of non-intercalating antibiotics to B-DNA. A theoretical study taking into account nucleic acid flexibility. J. Biomolec. Struct. Dyn. 3, 1155-1170.
28. Lee, M., Thodes, A.L., Wyatt, M.D., Forrow, S., and Hartley, J.A. (1993). GC base sequence recognition of oligo (imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, methidiumpropylethylene-diaminetetraacetate-iron (II) footprinting studies. Biochemistry 32, 4237-4245.
29. Lown, J.L. (1992). Lexitropsins in antiviral drug development. Antiviral Res. 17, 179-196.
30. Luck, G., Störl, J., Baguley, G., and Zimmer, Ch. (1992). DNA binding of the nonintercalative ligands SN 6132, SN 6131 and SN 6113: Minor variations of the ligand structure may cause changes in the base pair preference. J. Biomolec. Struct. Dyn. 10, 551-564.
31. Macgregor, Jr., R.B. (1992). Footprinting of EcoRI endonuclease at high pressure. Biochem. Biophys. Acta 1129, 303-308.
32. Maher, L.J. (1992). DNA triple-helix formation: An approach to artificial gene repressors? Bio Essays 14, 807-815.
33. Parraga, A., and Portugal, J. (1992). Detection of elsamicin-DNA binding specificity by restriction enzyme cleavage. FEBS Letters 300, 25-29.
34. Rosenberg, J.M. (1991). Structure and function of restriction endonucleases. Current Opinion in Structural Biology 1, 104-113.
35. Sayers, E.W., and Waring, M.J. (1993). Footprinting titration studies on the binding of echinomycin to DNA incapable of forming Hoogsteen base pairs. Biochemistry 32, 9094-9107.
36. Sidorova, N.Y., Gazoni, P., and Rau, D.C. (1995). Competition between netropsin and restriction nuclease EcoRI for DNA binding. J. Biomolec. Struct. Dyn. 13, 367-385.
37. Sun, J.S., and Hélène, C. (1993). Oligonucleotide-directed triplehelix formation. Curr. Opt. Struct. Biol. 3, 345-356.
38. Thuong, N.R., and Hélène, C. (1993). Sequenzspezifische Erkennung und Modifikation von Doppelhelix-DNA durch Oligonucleotide. Angew. Chem. 105, 697-723.
39. Uhlmann, E., and Peyman, A. (1990). Antisense oligonucleotides. A new therapeutic principle. Chem. Rev. 90, 544-584.
40. Waring, M.J., and Bailly, Ch. (1994). DNA recognition by intercalators and hybrid molecules. J. Molec. Recog. 7, 109-122.
41. Whitton, J.L. (1994). Antisense treatment of viral infection. Adv. Vir. Res. 44, 267-273.
42. Workman, P., Dincalci, M., Bredel, W.E., Erogin, M.J., Hélène, C., Hickman, J.A., Jarman, J., Schwarzmann, G., and Sikora, K. (1992). New approaches in cancer pharmacology: Drug design and development. Eur. J. Cane. 281, 1190-1200.
43. Zimmer, Ch., and Wähnert, U. (1986). Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Progr. Biophys. Molec. Biol. 47, 31-112.